Research for bleeding tendency in patients presenting with significant epistaxis

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 1, 2007, Pages 41-43

  Dizdar, Omer ^a   Onal, Ibrahim Koral ^a   Ozakin, Engin ^a   Karakiliç, Evvah ^a   Karadag, Omer ^a   Kalyoncu, Umut ^a   Coşkun, Figen ^a   Buyukasik, Yahya ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Bleeding tendency; Emergency department; Epistaxis

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; RISTOCETIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLEEDING DISORDER; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CLINICAL ARTICLE; EAR; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; EPISTAXIS; FAMILY HISTORY; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MALE; MUCOSAL BLEEDING; NOSE; PARTIAL THROMBOPLASTIN TIME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; THROAT; THROMBOCYTE COUNT;

ASPIRIN; BIOLOGICAL MARKERS; BLOOD COAGULATION DISORDERS, INHERITED; EPISTAXIS; FAMILY HEALTH; FEMALE; HEMORRHAGE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; QUESTIONNAIRES; RESEARCH;

EID: 33845767044     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3280110762     Document Type: Article

References (16)

1. Weiss NS. Relation of high blood pressure to headache, epistaxis, and selected other symptoms The United States Health Examination Survey of Adults. N Engl J Med 1972; 287:631-633.
2. Tan LK, Calhoun KH. Epistaxis. Med Clin North Am 1999; 83:43-56.
3. Viducich RA, Blanda MP, Gerson LW. Posterior epistaxis: clinical features and acute complications. Ann Emerg Med 1995; 25:592-596.
4. Beran M, Stigendal L, Petruson B. Haemostatic disorders in habitual nose-bleeders. J Laryngol Otol 1987; 101:1020-1028.
5. Sadler JE, Rodeghiero F. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005; 3:775-777.
6. Werner EJ. von Willebrand disease in children and adolescents. Pediatr Clin North Am 1996; 43:683-707.
7. Peyvandi F, Mannucci PM, Lak M, Abdoullahi M, Zeinali S, Sharifian R, Perry D. Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients. Br J Haematol 1998; 102:626-628.
8. Damrose JF, Maddalozzo J. Pediatric epistaxis. Laryngoscope 2006; 116:387-393.
9. Lak M, Sharifian R, Peyvandi F, Mannucci PM. Symptoms of inherited factor V deficiency in 35 Iranian patients. Br J Haematol 1998; 103:1067-1069.
10. Sandoval C, Dong S, Visintainer P, Ozkaynak MF, Jayabose S. Clinical and laboratory features of 178 children with recurrent epistaxis. J Pediatr Hematol Oncol 2002; 24:47-49.
11. Jones GL, Browning S, Phillipps J. The value of coagulation profiles in epistaxis management. Int J Clin Pract 2003; 57:577-578.
12. Thala MA, Nilssen EL, Holland S, Love G, White PS. Routine coagulation screening in the management of emergency admission for epistaxis - is it neccessary? J Laryngol Otol 2000; 114:38-40.
13. Herkner H, Laggner AN, Mullner M, Formanek M, Bur A, Gamper G, et al. Hypertension in patients presenting with epistaxis. Ann Emerg Med 2000; 35:126-130.
14. Herkner H, Havel C, Mullner M, Gamper G, Bur A, Temmel AF, et al. Active epistaxis at ED presentation is associated with arterial hypertension. Am J Emerg Med 2002; 20:92-95.
15. Watson MG, Shenoi PM. Drug-induced epistaxis? J R Soc Med 1990; 83:162-164.
16. Levi MM, Vink R, de Jonge E. Management of bleeding disorders by prohemostatic therapy. Int J Hematol 2002; 76 (Suppl 2):139-144.